Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Classical hematology 4Other hematologic neoplasm 3Lymphoid 3Myeloid 2Plasma cell 1CNS 1

Conditions

Leukemia, Myeloid, Acute 103Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Myelodysplastic Syndromes 89Leukemia 79Lymphoma 71Lymphoma, Non-Hodgkin 70Leukemia, Lymphocytic, Chronic, B-Cell 65Hodgkin Disease 55Multiple Myeloma 49Lymphoma, Mantle-Cell 42Lymphoma, Follicular 41Burkitt Lymphoma 39Lymphoma, Large B-Cell, Diffuse 38Lymphoma, B-Cell, Marginal Zone 36Lymphoma, Large-Cell, Immunoblastic 33Myeloproliferative Disorders 32Hematologic Neoplasms 32Leukemia, Myelogenous, Chronic, BCR-ABL Positive 30Neoplasms, Plasma Cell 27Leukemia, Myeloid, Accelerated Phase 25Leukemia, Myeloid, Chronic-Phase 24Congenital Abnormalities 24Leukemia, Myelomonocytic, Chronic 23Graft vs Host Disease 22Dendritic Cell Sarcoma, Interdigitating 21Recurrence 20Anemia, Refractory, with Excess of Blasts 20Waldenstrom Macroglobulinemia 18Blast Crisis 18Primary Myelofibrosis 17

Interventions

fludarabine phosphate 4fludarabine 3Whole-Body Irradiation 3Thiotepa 3Melphalan 3Cyclophosphamide 3Therapeutics 2Busulfan 2Antilymphocyte Serum 2Alemtuzumab 2thymoglobulin 1fosphenytoin 1Vaccination 1Photopheresis 1Phenytoin 1Peripheral Blood Stem Cell Transplantation 1Injections 1Clofarabine 1Clinical Trials, Phase I as Topic 1Bone Marrow Transplantation 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Immunologic Deficiency Syndromes × Melphalan × Other hematologic neoplasm × Clear all
NCT03609827 2021-10-04

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡